// App-Quantinova.ai

P157 : Longterm outcomes of rheumatoid arthritis patients with severe osteoporosis treated with either Teriparatide or antiresorptive treatment – an observational study

Researchers

Presenter

  • Barbara Hauser

Principal Investigators

  • Stuart H. Ralston

Medical Centers

  • Rheumatology and Bone Disease Unit- Centre for Genomic and Experimental Medicine- MRC institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom

  • Nhs Lothian, Rheumatology, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Musculoskeletal

Disease

  • Rheumatoid arthritis

  • Osteoporosis

  • Inflammatory Arthritis

Biomarkers

  • Bone Mineral Density

Drug/Treatment

  • Teriparatide

  • Hydroxyzine

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved